July 2024: Fluoroquinolone antibiotics update

News

July 2024: Fluoroquinolone antibiotics update


Following a review of the effectiveness of current measures to reduce the risk of potentially long-term or irreversible side effects associated with fluoroquinolone antibiotics, the MHRA introduced further restrictions to limit fluoroquinolone use. The MHRA announced that fluoroquinolone antibiotics given systemically (by mouth, injection, or inhalation) must only be administered when no other antibiotics are appropriate for use.

The Devon Formulary has been updated to include the strengthened regulations from the MHRA and fluoroquinolones are now only to be used when other recommended antibiotics have failed, will not work due to resistance, or are unsafe to use in an individual patient.

See here for the drug page.

See here for other recent updates to the formulary.